“…To reduce fetal hazards, a low dosage, superficial technique of PCB has been advised by BLOOM [2] and by JÄGERHORN [10] and was also used in our study. The success rate (76%) and the failure rate (12%) we found using that technique are of a similar order to that reported when using larger bupivacaine dosages [17]. The plasma levels of bupivacaine after low dosage (25 mg) administration in maternal, fetal and neonatal blood are lower than reported by HYMAN [8] (maternal 0.14, neonatal 0.08ug/ml) or by BEAZLEY [1] (1.07 and 0.10), who used 50 mg of bupivacaine at PCB.…”